uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden..
Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden..
Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden..
Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden..
Show others and affiliations
2016 (English)In: Journal of Translational Medicine, ISSN 1479-5876, E-ISSN 1479-5876, Vol. 14, 128Article in journal (Refereed) Published
Resource type
Text
Abstract [en]

Background: Podocalyxin-like 1 (PODXL) is an anti-adhesive transmembrane protein that has been demonstrated to be an independent factor of poor prognosis in colorectal cancer (CRC). The gene encoding PODXL is located to chromosome 7, which also harbours the gene for the epidermal growth factor receptor (EGFR). The aim of this study was to examine the associations between PODXL and EGFR expression in CRC in vitro and in vivo.

Methods: EGFR expression was analysed in tumours from three independent patient cohorts; cohort 1 (n = 533), cohort 2 (n = 259) and cohort 3 (n = 310), previously analysed for immunohistochemical PODXL expression and KRAS and BRAF mutations (cohort 1 and 3). Levels of EGFR and PODXL were determined by western blot in six different CRC cell lines.

Results: High expression of PODXL was significantly associated with high EGFR expression (p < 0.001) in all three cohorts, and with BRAF mutation (p < 0.001) in cohort 1 and 3. High EGFR expression correlated with BRAF mutation (p < 0.001) in cohort 1. High EGFR expression was associated with adverse clinicopathological factors and independently predicted a reduced 5-year overall survival (OS) in cohort 1 (HR 1.77; 95 % CI 1.27-2.46), cohort 2 (HR 1.58; 95 % CI 1.05-2.38) and cohort 3 (HR 1.83; 95 % CI 1.19-2.81). The highest risk of death within 5 years was observed in patients with tumours displaying high expression of both EGFR and PODXL in cohort 1 and 3 (HR 1.97; 95 % CI 1.18-3.28 and HR 3.56; 95 % CI 1.75-7.22, respectively). Western blot analysis showed a uniform expression of PODXL and EGFR in all six examined CRC cell lines.

Conclusions: The results from this study demonstrate that high expression of EGFR is an independent factor of poor prognosis in CRC. Moreover, strong links have been uncovered between expression of the recently proposed biomarker candidate PODXL with EGFR expression in CRC in vivo and in vitro, and with BRAF mutation in vivo. High expression of both PODXL and EGFR may also have a synergistic adverse effect on survival. These findings suggest a potential functional link in CRC between PODXL, EGFR and BRAF, all originating from chromosome 7, which may be highly relevant in the clinical setting and therefore merit future in-depth study.

Place, publisher, year, edition, pages
2016. Vol. 14, 128
Keyword [en]
Podocalyxin-like, EGFR, BRAF, Colorectal cancer, Prognosis
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-297267DOI: 10.1186/s12967-016-0882-0ISI: 000375475400002PubMedID: 27160084OAI: oai:DiVA.org:uu-297267DiVA: diva2:942035
Funder
Knut and Alice Wallenberg FoundationSwedish Cancer SocietyGunnar Nilsson Cancer Foundation
Available from: 2016-06-23 Created: 2016-06-22 Last updated: 2017-11-28Bibliographically approved

Open Access in DiVA

fulltext(2260 kB)131 downloads
File information
File name FULLTEXT01.pdfFile size 2260 kBChecksum SHA-512
106bb73a4e8dc78843b2df556881d78a822695f247b7d2a2dc004a9e930061b6dd164f600a6106372fd45c568cae935f162d3bedb548306b515bedb6d2bb460b
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Sundström, MagnusBirgisson, Helgi

Search in DiVA

By author/editor
Sundström, MagnusBirgisson, Helgi
By organisation
Department of Immunology, Genetics and PathologyColorectal Surgery
In the same journal
Journal of Translational Medicine
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 131 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 339 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf